Sick with COVID and the flu: Double infections hit California hard

California’s hospitals are getting busier with more COVID-19 and flu patients, some of whom are suffering from both viruses at the same time.

RFK Jr.’s campaign of conspiracy theories

As pundits and politicos spar over whether Robert F. Kennedy Jr.’s presidential campaign will factor into the outcome of the 2024 election, one thing is clear: Kennedy’s political following is built on a movement that seeks to legitimize conspiracy theories.

4 years on, long COVID still confounds us; here’s what we now know

As many as 7% of Americans report having suffered from a slew of lingering symptoms after enduring COVID.

Everyone in California seems to be sick with respiratory illness. Here’s why

Does it seem like a lot of people you know are sick? You’re not alone. Respiratory illness season is in full swing in California and across much of the nation.

With pandemic aid expiring and most funds already spent, schools across Illinois face a financial cliff

School systems across the country are facing a financial cliff, whereby COVID-19 pandemic funds must be committed by September 2024 and spent by January 2025, raising questions on the sustainability and impact of new, federally funded investments.

How the anti-vaccine movement is gaining power in statehouses

Tennessee lawmakers dropped all vaccine requirements for home-schooled children. Iowa Republicans passed a bill eliminating the requirement that schools educate students about the HPV vaccine. And the Florida legislature passed a law preemptively barring school districts from requiring coronavirus vaccines

New coronavirus variant JN.1 is spreading fast. Here’s what to know.

The World Health Organization on Tuesday declared coronavirus subvariant JN.1 a variant of interest “due to its rapidly increasing spread.”

COVID-19 surge prompts return of scanners, calls for masks in Asian cities

Governments across Southeast Asia are bringing back measures to limit a rapid resurgence of respiratory infections such as COVID-19, including installing temperature scanners at airports and encouraging people to wear masks again.

Pfizer’s bleak forecast dims hope for rebound after 2023 rout

The 2023 decline has erased about $140 billion in market value amid skepticism that the company will be successful in its transition out of the pandemic as demand for shots and treatments for Covid-19 wanes.

COVID and flu rising ahead of holidays, increasing ER visits

Respiratory viruses are rebounding in the United States on the precipice of the end-of-year holidays, with emergency room visits for COVID-19, influenza and respiratory syncytial virus collectively reaching their highest levels since February.